From: Favorable outcomes with reduced steroid use in juvenile dermatomyositis
 | Monocyclic, n = 10 | Chronic Continuous, n = 18 |  |
---|---|---|---|
Myositis control (months) | 6.6 (4.3–7.8) (n = 10) | 6 (3.7–17.6) (n = 17) | p = 0.334 |
Cutaneous disease control (months) | 15.7 (13.1–17) (n = 9) | 29.6, (16.4–63.3) (n = 12) | p = 0.018 |
Duration of steroid use (months) | 8 (4.5–8.8) (n = 9) | 9.9 (7–30.4) (n = 18) | p = 0.145 |